Cover Image
Market Research Report

Global Digital Pathology Market - 2019-2026

Published by DataM Intelligence Product code 834570
Published Content info 130-180 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Digital Pathology Market - 2019-2026
Published: May 1, 2019 Content info: 130-180 Pages
Description

Global Digital Pathology Market Overview

The Global Digital Pathology market was valued at USD XX million in 2018 and expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.

Digital pathology is a dynamic, image-based environment that is enabled in part by virtual microscopy and that can view, manage and analyze the pathology information generated from a digitized glass slide. Healthcare applications consist of diagnosis, diagnostic consultation, medical training, clinical research, among many other applications. With the introduction of Whole-Slide Imaging, the field of digital pathology is currently regarded as one of the most promising avenues of diagnostic medicine to achieve an even faster and cheaper diagnosis, the prognosis of essential diseases.

Global Digital Pathology Market - Market Dynamics

The global market for the Digital Pathology Market is primarily driven by the rising prevalence of chronic conditions, high adoption of digital pathology systems and its accuracy in the pathological assessment. According to the World Health Organization, The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. WHO estimated that Infectious diseases kill over 17 million people a year, around the world. Additionally, the rising demand for personalized medicine, its advantage in reducing human error and improve the accuracy of diagnoses, increases the potential for using data for education and consultations and rapid technological advancements in digital pathology are expecting to play a crucial role in the development of the market.

However, lack of reimbursement policies and the high cost of digital pathology systems may hinder the market progress. According to a national survey conducted on behalf of National Cancer Research Institute's CM-Path initiative in UK, 82.5% of respondents agreed that initial financial cost was an obstacle to widespread usage of digital pathology in their institution. On the other hand, only 15% agreed that safety concerns were hampering more widespread use of digital slides.

Global Digital Pathology Market - Segment Analysis

By Product, the Global Digital Pathology Market is segmented into Software, Scanners, Storage Systems, and Communication Systems. The software market share is expected to witness the highest growth rate due to the availability of analytical, user-friendly, and advanced functions for pathology diagnosis. Technological advancements and product launches by key players are some factors that are anticipated to amplify the segment growth. For instance, in April 2019, Gestalt Diagnostics announced their development of an artificial intelligence algorithm that identifies and routes more critical cases first to the appropriate pathologist based upon a pathologist's specialty.

By Application, the Global Digital Pathology Market is segmented into Drug Discovery, Teleconsultation, Diagnosis, and Training & Education. The diagnosis sector accounts for a significant market share, in terms of revenue owing to the rising prevalence of diseases such as cancer. Additionally, the increasing attention of manufacturers on developing rapid and accurate diagnostic techniques is likely to encourage the growth of the segment.

By Technology, the Global Digital Pathology Market is segmented into Whole Slide Imaging and Telepathology. Telepathology is sub-segmented into static and dynamic. The Whole Slide Imaging segment dominates the market due to increasing acceptance and adoption of this system for academic research activities and enhanced resolution of the image. In the Telepathology share, the static system held a significant percentage of the segment owing it to its advantages such as cost-effectiveness, efficiency, and reliability. Though adoption of Telepathology is relatively low increasing R&D on applications of static and dynamic systems is expected to affect the usage rate of this technology positively. For instance, Hybrid Telepathology, which is the combination of static and dynamic telepathology, is expected to gain popularity as it has advantages of both the systems.

By Type, the digital pathology market is bifurcated into human and veterinary pathology. The human pathology segment accounts for the largest share of the market owing to the increasing number of cancer research activities.

Global Digital Pathology Market- Geographical Analysis

Geographically, the global market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa.

North America is the leading revenue contributor to the global market and is followed by Europe. It can be attributed to the rising in acceptance of the digital pathology system in the region and increasing incidents of cancer and chronic diseases. According to the estimates of the American Cancer Society, in 2018, there were 1,735,350 new cancer cases diagnosed, and in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. Other factors such as growing investments in R&D activities, favorable reimbursement policies, supportive government initiatives on the development of technologically advanced systems, and a strong presence of major players in the regions are supplementing the market growth of these regions. For instance, in April 2019, the UK invested $65M to set up five new AI digital pathology and imaging centers. Philips, GE Healthcare, Siemens and Leica are some of the companies that will be leading the new centers, according to the Department for Business, Energy and Industrial Strategy.

Asia Pacific is anticipated to exhibit the fastest CAGR during the forecast period due to the presence of a large patient population, improving healthcare infrastructure coupled with growing investments in the medical field, and demand for novel treatment options.

Global Digital Pathology Market- Competitive Analysis

Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches and R&D are other ways the leading players improve their market presence.

In April 2019, International medical imaging IT and cybersecurity company Sectra signed a digital pathology contract with the Region of Southern Denmark. The IT solution for handling digital pathology images will enable pathologists at the region's four hospitals to review and collaborate around cases in a way that is not possible with microscopes. This will increase efficiency in primary diagnostics, thereby improving cancer care.

In April 2019, HCG introduced US FDA approved digital pathology solution by Philips Intellisite Pathology Solutions across all its centers in India. This technology marks a step forward in cancer treatment through precision, speed, efficiency, and ease of use with immense potential to provide significant clinical benefits to both the physicians and patients.

In April 2019, Deep Lens Inc., a U.S.-based AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis raised $14 million in Series A funding. The Series A round was led by Northpond Ventures with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners.

In April 2019, Cancer informatics and digital pathology workflow solution provider Inspirata Europe Ltd announced their intention to bring two new artificial intelligence tools for surveillance, structuring, and reporting of pathology diagnoses to the UK and Ireland markets.

In January 2019, Roche announced the launch of its uPath enterprise software for digital pathology. uPath enhances the user experience by drastically decreasing image rendering times, integrating automated image analysis and improving efficiency by enabling an improved workflow for sharing cases between pathologists.

In December 2018, Cancer informatics and digital pathology workflow solution provider Inspirata Europe, Ltd. announced it has entered into a partnership agreement with Hamamatsu Photonics affording shared customers with the ability to view native Hamamatsu .ndpi images within Inspirata's Dynamyx digital pathology software.

Key Takeaways:

  • The global market for the Digital Pathology Market is primarily driven by the rising prevalence of chronic conditions, high adoption of digital pathology systems and its accuracy in the pathological assessment.
  • The software market share is expected to witness the highest growth rate due to the availability of analytical, user-friendly, and advanced functions for pathology diagnosis. The diagnosis sector accounts for a significant market share, in terms of revenue owing to the rising prevalence of diseases such as cancer.
  • North America is the leading revenue contributor to the global market and is followed by Europe. It can be attributed to the rising in acceptance of the digital pathology system in the region and increasing incidents of cancer and chronic diseases.
  • Key players are adopting strategies such as mergers and collaborations to stand out as strong competitors in the market. For instance, in December 2018, Inspirata Europe, Ltd. announced it has entered into a partnership agreement with Hamamatsu Photonics.

Why Purchase the Report?

  • Visualize the composition of the global Digital Pathology Market across each indication, in terms of Product and Application options, highlighting the key commercial assets and players.
  • Identify commercial opportunities in global Digital Pathology Market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the global Digital Pathology Market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key products of all major market players

Target Audience:

  • Equipment Suppliers/ Buyers
  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers
Table of Contents

Table of Contents

SECTION 1

1. Global Digital Pathology Market Methodology and Scope

  • 1.1 Research methodology
  • 1.2 Research Objective and Scope of the Report

SECTION 2

2. Global Digital Pathology Market - Market Definition and Overview

SECTION 3

3. Global Digital Pathology Market - Executive Summary

  • 3.1 Market Snippet by Product
  • 3.2 Market Snippet by Application
  • 3.3 Market Snippet by Type
  • 3.3 Market Snippet by Technology
  • 3.4 Market Snippet by End-user
  • 3.5 Market Snippet by Region

SECTION 4

4. Global Digital Pathology Market - Market Dynamics

  • 4.1 Market Impacting Factors
    • 4.1.1 Drivers
      • 4.1.1.1 Growing trend of digitalization in medical sector
      • 4.1.1.2 Increasing prevalence of chronic diseases and cancer
      • 4.1.1.3 Greater cost efficiency
      • 4.1.1.4 Driver 4
    • 4.1.2 Restraints
      • 4.1.2.1 High Cost of Digital Pathology Systems
      • 4.1.2.2 Restraint 2
    • 4.1.3 Opportunity
    • 4.1.4 Impact Analysis

SECTION 5

5. Global Digital Pathology Market - Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis
  • 5.5 Patent Analysis

SECTION 6

6. Global Digital Pathology Market - By Product

  • 6.1 Software
  • 6.2 Scanners
  • 6.3 Storage Systems
  • 6.4 Communication Systems

SECTION 7

7. Global Digital Pathology Market - By Application

  • 7.1 Drug Discovery
  • 7.2 Teleconsultation
  • 7.3 Diagnosis
  • 7.4 Training & Education

SECTION 8

8. Global Digital Pathology Market - By Type

  • 8.1 Human Pathology
  • 8.2 Veterinary Pathology

SECTION 9

9. Global Digital Pathology Market - By Technology

  • 9.1 Whole Slide Imaging
  • 9.2 Telepathology
    • 9.2.1 Static Telepathology
    • 9.2.2 Dynamic Telepathology

SECTION 10

10. Global Digital Pathology Market - By End-user

  • 10.1 Pharmaceutical and Biotechnology Companies
  • 10.2 Contract Research Organizations
  • 10.3 Research & Academic Institutes
  • 10.4 Hospital laboratories

SECTION 11

11. Global Digital Pathology Market - By Region

  • 11.1 North America
    • 11.1.1 U.S.
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 U.K.
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Rest of Europe
  • 11.3 South America
    • 11.3.1 Brazil
    • 11.3.2 Argentina
    • 11.3.3 Rest of South America
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 India
    • 11.4.3 Japan
    • 11.4.4 Australia
    • 11.4.5 Rest of Asia Pacific
  • 11.5 The Middle East and Africa

SECTION 12

12. Global Digital Pathology Market - Competitive Landscape

  • 12.1 Competitive Scenario
  • 12.2 Competitor Strategy Analysis
  • 12.3 Comparative Product Portfolio Analysis
  • 12.4 Market Positioning/Share Analysis
  • 12.5 Mergers and Acquisitions Analysis

SECTION 13

13. Company Profiles

  • 13.1 Philips Healthcare
  • 13.2 3DHistech Inc.
  • 13.3 Hamamatsu Photonics
  • 13.4 Ventana Medical Systems Inc.
  • 13.5 GE Healthcare
  • 13.6 Leica Biosystems
  • 13.7 Definiens AG
  • 13.8 Olympus Corporation
  • 13.9 Inspirata Co.
  • 13.10 MicroSkan Technologies
  • 13.11 Roche Group

SECTION 14

14. Global Digital Pathology Market - Premium Insights

SECTION 15

15. Global Digital Pathology Market - DataM

  • 15.1 Appendix
  • 15.2 About Us and Services
  • 15.3 Contact Us
Back to Top